T helper type 17 cells in immune-mediated glomerular disease

Area of Science:

• Immunology
• Nephrology

Background:

• CD4⁺ T cells, particularly T helper 17 (T_H17) cells, are key contributors to tissue damage in immune-mediated renal diseases.
• T_H17 cells are defined by RORγt expression and production of IL-17A, IL-17F, and IL-22, alongside CCR6 expression.

Purpose of the Study:

• To elucidate the identification, regulation, and function of T_H17 cells in immune-mediated kidney diseases.
• To focus on the mechanisms of renal tissue injury driven by T_H17 cells.
• To discuss therapeutic strategies targeting T_H17 pathways in autoimmune kidney disease.

Main Methods:

• Review of experimental models and human studies.
• Analysis of T_H17 cell characteristics (RORγt, IL-17A, IL-17F, IL-22, CCR6).
• Investigation of T_H17 cell involvement in renal damage.

Main Results:

• T_H17 cells play a significant role in the pathogenesis of various glomerulonephritis types and lupus nephritis.
• Evidence supports targeting T_H17 cell development, migration, or function within the kidney.
• Specific pathways involving T_H17 cells have been identified as crucial for renal injury.

Conclusions:

• T_H17 cells are critical mediators of renal damage in autoimmune kidney diseases.
• Understanding T_H17 cell biology provides a rationale for developing targeted therapies.
• Inhibiting T_H17 cells presents a promising therapeutic avenue for patients with autoimmune renal conditions.